NO152048C - Analogifremgangsmaate ved fremstilling av nye, terapeutisk aktive 5h-2,3-benzodiazepinderivater - Google Patents

Analogifremgangsmaate ved fremstilling av nye, terapeutisk aktive 5h-2,3-benzodiazepinderivater

Info

Publication number
NO152048C
NO152048C NO793349A NO793349A NO152048C NO 152048 C NO152048 C NO 152048C NO 793349 A NO793349 A NO 793349A NO 793349 A NO793349 A NO 793349A NO 152048 C NO152048 C NO 152048C
Authority
NO
Norway
Prior art keywords
preparation
therapeutically active
benzodiazepine derivatives
new therapeutically
analogy procedure
Prior art date
Application number
NO793349A
Other languages
English (en)
Norwegian (no)
Other versions
NO152048B (no
NO793349L (no
Inventor
Jozsef Borsy
Jeno Koeroesi
Tibor Lang
Jozsef Szekely
Ferenc Andrasi
Gabor Zolyomi
Katalin Goldschmidt
Tamas Hamori
Gabriella Szabo
Zsuzsa Meszaros
Erzsebet Miglecz
Original Assignee
Egyt Gyogyszervegyeszeti Gyar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egyt Gyogyszervegyeszeti Gyar filed Critical Egyt Gyogyszervegyeszeti Gyar
Publication of NO793349L publication Critical patent/NO793349L/no
Publication of NO152048B publication Critical patent/NO152048B/no
Publication of NO152048C publication Critical patent/NO152048C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/02—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/76—Benzo[c]pyrans
NO793349A 1978-10-19 1979-10-18 Analogifremgangsmaate ved fremstilling av nye, terapeutisk aktive 5h-2,3-benzodiazepinderivater NO152048C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU78GO1426A HU179018B (en) 1978-10-19 1978-10-19 Process for producing new 5h-2,3-benzodiazepine derivatives

Publications (3)

Publication Number Publication Date
NO793349L NO793349L (no) 1980-04-22
NO152048B NO152048B (no) 1985-04-15
NO152048C true NO152048C (no) 1985-07-24

Family

ID=10996876

Family Applications (1)

Application Number Title Priority Date Filing Date
NO793349A NO152048C (no) 1978-10-19 1979-10-18 Analogifremgangsmaate ved fremstilling av nye, terapeutisk aktive 5h-2,3-benzodiazepinderivater

Country Status (25)

Country Link
US (1) US4322346A (de)
JP (1) JPS5592377A (de)
AT (1) AT373589B (de)
AU (1) AU532079B2 (de)
BE (1) BE879404A (de)
BG (1) BG60270B1 (de)
CA (1) CA1125749A (de)
CH (1) CH643835A5 (de)
CS (1) CS236456B2 (de)
DD (1) DD146596A5 (de)
DE (1) DE2940483A1 (de)
DK (1) DK155327C (de)
ES (1) ES485163A1 (de)
FI (1) FI66604C (de)
FR (1) FR2439189A1 (de)
GB (1) GB2034706B (de)
GR (1) GR74034B (de)
HU (1) HU179018B (de)
IT (1) IT1220947B (de)
NL (1) NL190552C (de)
NO (1) NO152048C (de)
PL (1) PL124063B1 (de)
SE (1) SE439919B (de)
SU (1) SU1402258A3 (de)
YU (1) YU41887B (de)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU186760B (en) * 1981-03-12 1985-09-30 Gyogyszerkutato Intezet Process for preparing 3,4-dihydro-5h-2,3-aenzodiazepine derivatives
HU191702B (en) * 1984-06-27 1987-03-30 Gyogyszerkutato Intezet New process for preparing 1-aryl-5 h-2,3-benzodiazepines
HU191698B (en) * 1984-07-27 1987-03-30 Gyogyszerkutato Intezet Process for producing new 1-aryl-5h-2beta-benzodiazepines
HU195788B (en) * 1986-05-21 1988-07-28 Gyogyszerkutato Intezet Process for producing 1-/hydroxy-stiryl/-5h-2,3-benzobiazepines and pharmaceutical compositions containing them
JPH01311400A (ja) * 1988-06-09 1989-12-15 Kyocera Corp 発光標識体の点灯方法
JPH0251568U (de) * 1988-10-07 1990-04-11
JPH0324693U (de) * 1989-07-18 1991-03-14
HU207055B (en) * 1990-10-17 1993-03-01 Gyogyszerkutato Intezet Process for producing new 5h-2,3-benzodiazepine derivative and pharmaceutical compositions comprising same
HU208429B (en) * 1991-05-03 1993-10-28 Gyogyszerkutato Intezet Process for producing 1-/3-chloro-phenyl/-4-methyl-7,8-dimethoxy-5h-2,3-benzodiazepine of high purity
JP3497164B2 (ja) * 1991-06-28 2004-02-16 スミスクライン・ビーチャム・コーポレイション 二環式フィブリノーゲン拮抗薬
US5939412A (en) * 1992-06-26 1999-08-17 Smithkline Beecham Corporation Bicyclic fibrinogen antagonists
US6458784B1 (en) 1994-06-29 2002-10-01 Smithkline Beecham Corporation Vitronectin receptor antagonists
HU224435B1 (hu) * 1995-02-09 2005-10-28 EGIS Gyógyszergyár Rt. Benzodiazepin-származékok, eljárás előállításukra, alkalmazásukra és ezeket tartalmazó gyógyászati készítmények
DE69612413T2 (de) * 1995-02-09 2001-09-27 Egyt Gyogyszervegyeszeti Gyar 1-(Hetero)Arylvinyl-5H-2,3-benzodiazepinderivative verwendbar zur Behandlung von Erkrankungen des Zentralnervensystems, sowie Benzopyrylium Intermediate zu ihrer Herstellung
SK283859B6 (sk) * 1995-02-09 2004-03-02 EGIS Gyógyszergyár Rt. 1-[2'-(Substituovaný)vinyl]-5H-2,3-benzodiazepínové deriváty, spôsob ich prípravy a medziprodukty na ich prípravu, liečivá ich obsahujúce a ich použitie
US5977101A (en) * 1995-06-29 1999-11-02 Smithkline Beecham Corporation Benzimidazoles/Imidazoles Linked to a Fibrinogen Receptor Antagonist Template Having Vitronectin Receptor Antagonist Activity
DE19604920A1 (de) * 1996-02-01 1997-08-07 Schering Ag Neue 2,3-Benzodiazepinderivate, deren Herstellung und Verwendung als Arzneimittel
ES2111493B1 (es) * 1996-02-08 1999-08-01 Egyt Gyogyszervegyeszeti Gyar Derivados de 1-(2- (vinilo substituido ) ) -5h-2,3-benzo-diazepina, procedimiento para su preparacion, composiciones farmaceuticas que los contienen y utilizaciones correspondientes.
ZA972746B (en) * 1996-04-04 1998-10-09 Egyt Gyogyszervegyeszeti Gyar Novel 2,3-benzodiazepine derivatives
HU9600871D0 (en) * 1996-04-04 1996-05-28 Gyogyszerkutato Intezet New 2,3-benzodiazepine derivatives
HUP9701284A3 (en) * 1997-07-24 2005-11-28 Egyt Gyogyszervegyeszeti Gyar Use of 2,3-benzodiazepine derivatives for producing pharmaceutical compositions for treating and prophylacting illnesses and conditions connected with the endogene opioide system
HU227128B1 (en) * 1999-07-07 2010-07-28 Egyt Gyogyszervegyeszeti Gyar New 2,3-benzodiazepine derivatives
FR2824065A1 (fr) * 2001-04-26 2002-10-31 Neuro3D Composes inhibiteurs des phosphodiesterases des nucleotides cycliques, preparation et utilisations
US6649607B2 (en) * 2001-05-18 2003-11-18 Vela Pharmaceuticals, Inc. Compositions and methods for treating or preventing convulsions or seizures
JP4630665B2 (ja) * 2002-09-13 2011-02-09 モタック・ニューロサイエンス・リミテッド ２，３−ベンゾジアゼピンによる基底核関連運動障害の治療
CA2499200A1 (en) * 2002-09-17 2004-04-01 Motac Neuroscience Limited Use of compounds in the treatment of dyskinesia
US7022700B2 (en) * 2002-12-03 2006-04-04 Vela Pharmaceuticals, Inc. Method of increasing neutrophil production using optically-pure (R)-2,3-benzodiazepines
US6638928B1 (en) 2002-12-03 2003-10-28 Vela Pharmaceuticals, Inc. Treatment of irritable bowel syndrome and nonulcer dyspepsia with substituted 2,3-benzodiazepines
US6864251B2 (en) * 2002-12-03 2005-03-08 Vela Pharmaceuticals, Inc. Treatment of LTB4-mediated inflammatory disorders with optically-pure (R)-2,3-benzodiazepines
JP2006514084A (ja) * 2002-12-03 2006-04-27 ヴェラ ファーマスーティカルズ インコーポレイテッド １−（３−ヒドロキシ−４−メトキシフェニル）−４−メチル−５−エチル−７，８−ジメトキシ−５ｈ−２，３−ベンゾジアゼピンの製薬組成物及びその用途
AU2003293405A1 (en) * 2002-12-03 2004-06-23 Vela Pharmaceuticals, Inc. Pharmaceutical composition of 1-(3,4-dimethoxyphenyl)-4-methyl-5-ethyl-7-methoxy-8-hydroxy-5h-2,3-benzodiazepine and uses thereof
US20040224943A1 (en) * 2003-02-19 2004-11-11 Leventer Steven M. Method of lowering body temperature with (R) - 2,3-benzodiazepines
US20040162284A1 (en) * 2003-02-19 2004-08-19 Harris Herbert W. Method of lowering body temperature with (S) tofisopam
WO2004103154A2 (en) * 2003-05-16 2004-12-02 Vela Pharmaceuticals, Inc. Treatment of gastrointestinal dysfunction and related stress with an enantiomerically-pure (r) 2,3-benzodiazepine
US20070021412A1 (en) * 2003-05-16 2007-01-25 Vela Pharmaceuticals, Inc. Treatment of gastrointestinal dysfunction and related stress with an enantiomerically-pure (S) 2,3-benzodiazepine
US20040254173A1 (en) * 2003-06-13 2004-12-16 Leventer Steven M. Modulation of dopamine responses with substituted (S)-2,3-benzodiazepines
HUP0302449A3 (en) * 2003-08-04 2005-06-28 Egis Gyogyszergyar Nyilvanosan 8-chloro-2,3-benzodiazepine derivatives, pharmaceutical compositions containing them and process for producing them
US7541355B2 (en) * 2005-05-23 2009-06-02 Vela Acquisition Corporation Conversion process for 2,3-benzodiazepine enantiomers

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1202579A (en) * 1966-12-09 1970-08-19 Egyt Gyogyszervegyeszeti Gyar Pharmacologically active new isoquinoline derivative and process for preparing same
DK118660B (da) * 1966-12-09 1970-09-21 Egyt Gyogyszervegyeszeti Gyar Analogifremgangsmåde til fremstilling af 1-(3',4'-dimethoxyphenyl)-3-methyl-4-ethyl-6,7-dimethoxy-isoquinolin-N-imid.
USRE30014E (en) 1966-12-09 1979-05-29 Egyesult Gyogyazer-es Tapozergyar 1-(3,4-Dimethoxy-phenyl)-4-methyl-5-ethyl-7,8-dimethoxy-5H-2,3-benzodiazepine
ZA712798B (en) * 1970-11-06 1972-02-23 Egyt Gyogyszervegyeszeti Gyar New,pharmaceutically active 2,3-diazabicyclo(5.4.0)undecapentaene derivative and process for preparing same

Also Published As

Publication number Publication date
SU1402258A3 (ru) 1988-06-07
JPS5592377A (en) 1980-07-12
DK155327C (da) 1989-08-21
IT1220947B (it) 1990-06-21
AU532079B2 (en) 1983-09-15
IT7926579A0 (it) 1979-10-18
BG60270B2 (bg) 1994-03-31
ES485163A1 (es) 1980-06-16
SE439919B (sv) 1985-07-08
US4322346A (en) 1982-03-30
ATA647279A (de) 1983-06-15
DE2940483A1 (de) 1980-04-30
BE879404A (fr) 1980-04-15
FI66604C (fi) 1984-11-12
DE2940483C2 (de) 1989-06-22
PL124063B1 (en) 1982-12-31
CH643835A5 (de) 1984-06-29
NO152048B (no) 1985-04-15
PL219034A1 (de) 1980-12-01
FI793209A (fi) 1980-04-20
YU241079A (en) 1984-02-29
BG60270B1 (bg) 1994-03-31
AT373589B (de) 1984-02-10
SE7908481L (sv) 1980-04-20
NL190552C (nl) 1994-04-18
JPS6350354B2 (de) 1988-10-07
YU41887B (en) 1988-02-29
DK155327B (da) 1989-03-28
NL190552B (nl) 1993-11-16
CS236456B2 (en) 1985-05-15
CA1125749A (en) 1982-06-15
GB2034706A (en) 1980-06-11
FR2439189B1 (de) 1984-11-30
NL7907692A (nl) 1980-04-22
DD146596A5 (de) 1981-02-18
HU179018B (en) 1982-08-28
GB2034706B (en) 1982-08-04
FR2439189A1 (fr) 1980-05-16
GR74034B (de) 1984-06-06
DK440179A (da) 1980-04-20
FI66604B (fi) 1984-07-31
NO793349L (no) 1980-04-22

Similar Documents

Publication Publication Date Title
NO152048C (no) Analogifremgangsmaate ved fremstilling av nye, terapeutisk aktive 5h-2,3-benzodiazepinderivater
NO151085C (no) Analogifremgangsmaate ved fremstilling av nye, terapeutisk aktive peptidylargininaldehydderivater
NO153136C (no) Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive naftyridinderivater.
NO154964C (no) Analogifremgangsmaate ved fremstilling av nye, terapeutisk aktive piperidinderivater.
NO154919C (no) Analogifremgangsmaate ved fremstilling av nye kinazolinderivater.
NO152841C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive nye 4-aroylimidazol-2-oner.
NO154883C (no) Analogifremgangsmaate ved fremstilling av nye, terapeutisk aktive 2-acylaminomethyl-1,4-benzodiazepiner.
NO154521C (no) Analogifremgangsmaate for fremstilling av nye, terapeutisk aktive piperidinderivater.
NO160211C (no) Analogifremgangsmaate til fremstilling av nye terapeutisk virksomme cefemderivater.
NO147148C (no) Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive fenyletanolaminderivater
NO149174C (no) Analogifremgangsmaate ved fremstilling av nye terapeutisk virksomme tiazinderivater
NO162115C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 5h-2,3-benzodiazepinderivater.
NO149733C (no) Analogifremgangsmaate ved fremstilling av nye, terapeutisk aktive acylderivater av carnitin
NO166320C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive tetrazolderivater.
NO154426C (no) Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive trans-3-(4-okso-4h-kinazolin-3-yl)-2-propensyrederivater.
NO150884C (no) Analogifremgangsmaate for fremstilling av nye, terapeutisk aktive imidazotiazolderivater
NO146392C (no) Analogifremgangsmaate ved fremstilling av nye analgesisk aktive n-acetyl-para-aminofenyl-n`-acetyl-aminoalkansyreester-derivater
NO148642C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive, nye prostacyclinderivater
NO152654C (no) Analogifremgangsmaate ved fremstilling av nye, terapeutisk aktive derivater av 7-acylamido-3-cephem-4-karboksylsyre
NO148926C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive, nye merkaptoimidazolderivater
NO152444C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 4-fenyl-1,3-benzodiazepiner
NO154920C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive, nye pyridothienotriaziner.
NO142625C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive, nye piperazinderivater
NO150041C (no) Analogifremgangsmaate ved fremstilling av nye, terapeutisk aktive lactamforbindelser
NO154396C (no) Analogifremgangsmaate ved fremstilling av nye, terapeutisk aktive halovincamonderivater.